Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingyin Qinghua Recipe (also known as Jingyin Qinghua Fang) is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is primarily investigated for the treatment of mild or asymptomatic COVID-19 (coronavirus disease 2019). The recipe is designed to clear heat and detoxify, common principles in TCM for viral respiratory infections. In clinical studies, it has been compared to other TCM treatments like Lianhua Qingwen granules to evaluate its efficacy in promoting viral clearance and symptom resolution in patients infected with SARS-CoV-2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingyin Qinghua Recipe.